Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs

Simple item page
dc.contributor.authorJones, J. R.
dc.contributor.authorBarber, A.
dc.contributor.authorLe Bihan, Y-V
dc.contributor.authorWeinhold, N.
dc.contributor.authorAshby, C.
dc.contributor.authorWalker, B. A.
dc.contributor.authorWardell, C. P.
dc.contributor.authorWang, H.
dc.contributor.authorKaiser, M. F.
dc.contributor.authorJackson, G. H.
dc.contributor.authorDavies, F. E.
dc.contributor.authorChopra, R.
dc.contributor.authorMorgan, G. J.
dc.contributor.authorPawlyn, C.
dc.contributor.departmentGraduate Medical Education, School of Medicine
dc.date.accessioned2024-07-18T15:22:02Z
dc.date.available2024-07-18T15:22:02Z
dc.date.issued2021
dc.eprint.versionFinal published version
dc.identifier.citationJones JR, Barber A, Le Bihan YV, et al. Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs. Leukemia. 2021;35(10):3017-3020. doi:10.1038/s41375-021-01373-4
dc.identifier.urihttps://hdl.handle.net/1805/42312
dc.language.isoen_US
dc.publisherSpringer Nature
dc.relation.isversionof10.1038/s41375-021-01373-4
dc.relation.journalLeukemia
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectMultiple myeloma
dc.subjectTumor biomarkers
dc.subjectNeoplasm drug resistance
dc.titleMutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Jones2021Mutations-CCBY.pdf
Size:
960.73 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles